Evaluation of RNA-binding motif protein 3 expression in urothelial carcinoma of the bladder: an immunohistochemical study

Table 3 Comparison of studied parameters between our study and the only other study on RBM3 in urothelial carcinoma

	Current study	Boman et al. [18]
Specimen type and tumor stage^a	Cystectomies	Bladder biopsies
Specimen type and tumor stage^a	Cystectomies	Transurethral resections of bladder tumors (TURBTs)
Distribution of high-grade disease	274/274 (100 %)	261/343 (76 %)
Categorization of patient groups	Tumor stage
	Lymph node involvement	Tumor stage
	Lymphovascular invasion	Tumor grade
	Surgical resection margin status
RBM3 IHC scoring	H-score (continuous variable)	Dichotomized and trichotomized nuclear scores

^aPatients undergoing cystectomy for urothelial carcinoma have a worse prognosis due to muscle-invasive (higher stage) disease compared to patients who can initially be managed medically (intravesicular bacillus Calmette-Guerin treatment) based on biopsy or TURBT results (non-muscle-invasive or lower stage disease)

ISSN: 1477-7819